Sponsors soon may have no choice but to develop master protocols and similar trial designs for coronavirus treatments, as there now are concerns there may not be enough researchers to handle the workload.
Woodcock Warns Research Apparatus Could Be Overwhelmed If Coronavirus Trials Don’t Use Master Protocols
CDER Director Janet Woodcock says researchers need to embrace pragmatic trial designs and compare multiple treatments at the same time rather than employ separate development programs.
